Cite
HARVARD Citation
Ghoshdastidar, K. et al. (2020). ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer. Pharmacology research & perspectives. 8 (4), p. n/a. [Online].